Status:
UNKNOWN
The Characteristic of Airway Microbiome Profiling of COPD-bronchiectasis Overlap Patients and Its Association With Acute Exacerbation
Lead Sponsor:
Guangzhou Medical University
Conditions:
Bronchiectasis Adult
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
18-80 years
Brief Summary
The overlap between chronic obstructive pulmonary disease (COPD) and bronchiectasis is a neglected area of research, and it is not covered by guidelines for clinical practice. COPD and bronchiectasis...
Eligibility Criteria
Inclusion
- Diagnosed as COPD, bronchiectasis or overlap based on HRCT and lung function test.
- Aged between 18 and 80 years.
Exclusion
- Patients with active tuberculosis, traction bronchiectasis, malignancy, and severe systemic diseases.
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2023
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT04865861
Start Date
May 1 2021
End Date
June 30 2023
Last Update
May 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Guangzhou Medical University.
Guangzhou, Guangdong, China